NCT02900716 · Interventional trial
Safety Study of BTK Inhibitor, DTRMWXHS-12, Used Singly or in Combination, in CLL and B-cell Lymphomas
Overall registry status Completed
Phase 1
Conditions B-Cell Lymphoma, Chronic Lymphocytic Leukemia
Delaware Valley sites
- University of Pennsylvania Abramson Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory